Cargando…
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
Little is known on the long-lasting humoral response and the T cell activation induced by SARS-CoV-2 mRNA vaccines in patients with cancer. The study assessed the efficacy of the SARS-CoV-2 mRNA vaccines through measuring the seroconversion rate at pre-specified time points and the effect on the T c...
Autores principales: | Bordry, Natacha, Addeo, Alfredo, Jaksic, Cyril, Dutoit, Valérie, Roux-Lombard, Pascale, Shah, Dimpy P., Shah, Pankil K., Gayet-Ageron, Angèle, Friedlaender, Alex, Bugeia, Sébastien, Gutknecht, Garance, Battagin, Anna, Di Marco, Maragrazia, Simand, Pierre-Francois, Labidi-Galy, Intidhar, Fertani, Sarah, Sandoval, José, Dietrich, Pierre-Yves, Mach, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704782/ https://www.ncbi.nlm.nih.gov/pubmed/34977496 http://dx.doi.org/10.1016/j.isci.2021.103699 |
Ejemplares similares
-
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
por: Addeo, Alfredo, et al.
Publicado: (2021) -
In health research publications, the number of authors is strongly associated with collective self-citations but less so with citations by others
por: Jaksic, Cyril, et al.
Publicado: (2023) -
Correction: In health research publications, the number of authors is strongly associated with collective self-citations but less so with citations by others
por: Jaksic, Cyril, et al.
Publicado: (2023) -
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients
por: Bordry, Natacha, et al.
Publicado: (2023) -
Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation
por: Terzic, Julie, et al.
Publicado: (2020)